The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Siuch N.I.

V.G. Korolenko City Clinical Hospital No 14, Mocow

Machkalian K.É.

GBUZ Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia

Bragina E.E.

NII fiziko-khimicheskoĭ biologii im. A.N. Belozerskogo MGU im. M.V. Lomonosova

The ultrastructure of Trichomonas vaginalis: mutagen (nitrosoguanidine) - induced adaptive variability

Authors:

Siuch N.I., Machkalian K.É., Bragina E.E.

More about the authors

Read: 3537 times


To cite this article:

Siuch NI, Machkalian KÉ, Bragina EE. The ultrastructure of Trichomonas vaginalis: mutagen (nitrosoguanidine) - induced adaptive variability. Russian Journal of Clinical Dermatology and Venereology. 2012;10(6):80‑87. (In Russ.)

Recommended articles:
Ultrastructural and morphometric features of follicular thyroid adenomas. Russian Journal of Archive of Pathology. 2026;(1):18-25

References:

  1. Hook E.W. Trichomonas vaginalis - no longer a minor STD. Sex Transm Dis 1999; 26: 7: 388-389.
  2. Schwebke J.R., Burgess D. Trichomoniasis. Clin Microbiol Rev 2004; 17: 4: 794-803.
  3. Stark J.R., Judson G., Alderete J.F. et al. Prospective Study of Trichomonas vaginalis infection and Prostate cancer incidence and Mortality:Physicians Health Study. J Nat Cancer Inst 2009; 101: 20: 1406-1411.
  4. Dmitriev G.A., Syuch N.I. Mochepolovoi trikhomoniaz (kliniko-laboratornoe obsledovanie i vedenie patsientov). M: Meditsinskaya kniga 2005; 5.
  5. Batkaev E.A., Ryumin D.V. Opyt primeneniya vaktsiny "Solkotrikhovak" v kompleksnoi terapii mochepolovogo trikhomoniaza i bakterial'nogo vaginoza. IPPP 2001; 2: 32-37.
  6. Il'in I.I. Negonokokkovye uretrity u muzhchin. M 1991; 228.
  7. Svishcheva T.Ya. Raku mozhno protivostoyat'. M: Dion 1998; 190.
  8. Iannino A., Tesla P. Local treatment of vaginitis due to T. vaginalis. Comparative studies on methyl-partricin and metronidazole. Minerva Ginecol 1975; 27: 11: 929-932.
  9. Kopylov V.M., Bochkarev E.G., Govorun V.M. i dr. Urogenital'nyi trikhomoniaz. Aktual'nye voprosy diagnostiki i lecheniya. Posobie dlya vrachei. M: MIA 2001; 1-25.
  10. Kozhnye i venericheskie bolezni: Rukovodstvo dlya vrachei. V 2 t. 2-e izd. T. 1. Pod red. Yu.K. Skripkina, V.N. Mordovtseva. M: Meditsina 1999; 640-649.
  11. Razdol'skaya N.V., Gavrilova O.V., Telichko I.N i dr. Izuchenie ul'trastrukturnoi organizatsii virulentnykh form Trichomonas vaginalis. Mikrobiologiya 2007; 5: 8: 283-291.
  12. Upcroft P., Upcroft J.A. Drug targets and mechanisms of resistence in the anaerobic protozoa. Clin Microbiol Rev 2001; 14: 1: 150-164.
  13. Syuch N.I., Machkalyan K.E. Vliyanie nitrozoguanidina na morfologicheskie kharakteristiki vlagalishchnykh trikhomonad. Terapiya sotsial'no znachimykh zabolevanii v dermatovenerologii. Novye lekarstvennye preparaty i sredstva v dermatologii i kosmetologii. Nauchno-prakticheskaya konferentsiya, 4-i: Sbornik tezisov. M 2004; 186-187.
  14. Petrin D., Delgaty K., Bhatt R., Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11: 2: 300-317.
  15. Ryan K.J., Ray C.G., Sherris J.C. (eds.). Sherris Medical Microbiology. 4-th ed. Mc Graw Hill 2004.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.